Cannara Biotech Inc. (TSXV:LOVE)
Canada · Delayed Price · Currency is CAD 1.850
+0.130 (7.56%)
Nov 24, 2025, 3:54 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 163.22 million as of November 24, 2025. Its market cap has increased by 141.76% in one year.
Market Cap
163.22M
Enterprise Value
196.28M
Revenue
107.32M
Ranking
n/a
PE Ratio
12.29
Stock Price
1.85
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 163.22M, a decrease of -22.87%. That is a compound annual growth rate of -3.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 163.22M | 145.02% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | 59.03M | -33.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.32B |
| dentalcorp Holdings | 2.17B |
| Sienna Senior Living | 1.93B |
| Green Thumb Industries | 1.92B |
| Extendicare | 1.70B |
| Cronos Group | 1.28B |
| Trulieve Cannabis | 1.27B |
| WELL Health Technologies | 992.68M |